ESC 365 - Estimate and prognosis of patients who are candidates for treatment with eicosapentaenoic acid after an acute coronary syndrome

ESC Professional Premium Access

Estimate and prognosis of patients who are candidates for treatment with eicosapentaenoic acid after an acute coronary syndrome

Session: Lipids in heart disease

Topic: Drug therapy

Speaker: Doctor A. Cordero (Elche, ES)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Alberto Cordero

IMED Elche Hospital, Elche (Spain)

4 presentations

0 follower

8 more presentations in this session

Is the obesity paradox leading to a less stringent secondary prevention strategy in post-acute coronary syndrome patients?

Speaker: Mr M. Moreira (Penafiel, PT)

Outcomes of post-acute coronary syndrome patients enrolled in a phase 2 cardiac rehabilitation program

Speaker: Mr M. Moreira (Penafiel, PT)

Temporal trends in lipid management among Korean patients following acute myocardial infarction from 2011 to 2020

Speaker: Doctor S. Oh (Gwangju, KR)

Effect of triglycerides on cardiovascular risk in patients with a first vs. recurrent acute coronary syndrome

Speaker: Doctor A. Cordero (Elche, ES)

Statin use before acute coronary syndrome and coronary risk factors, clinical presentation, interventions, and outcomes: ACC-NCDR-CathPCI Registry in India

Speaker: Professor R. Gupta (Jaipur, IN)

Access the full session

Lipids in heart disease

Speakers: Doctor A. Cordero, Mr M. Moreira, Mr M. Moreira, Doctor S. Oh, Doctor A. Cordero...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources